Lipopeptide Antibacterial [EPC]

Lipopeptide Antibacterial [EPC] was reported 9504 times

Drugs of the Lipopeptide Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION 24 0.7273
1 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
2 PROTOTHECOSIS 24 0.2553
3 AORTOENTERIC FISTULA 13 0.2031
4 EOSINOPHILIC PNEUMONIA ACUTE 149 0.1721
5 EOSINOPHILIC PNEUMONIA 489 0.1550
6 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 47 0.1521
7 BAND NEUTROPHIL COUNT DECREASED 7 0.1061
8 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 15 0.1056
9 INTRACRANIAL INFECTION 13 0.1040
10 CHIMERISM 8 0.0899
11 OSTEOMYELITIS FUNGAL 15 0.0898
12 MENINGITIS ENTEROCOCCAL 7 0.0886
13 ALVEOLAR LUNG DISEASE 15 0.0789
14 AUTOIMMUNE ANAEMIA 4 0.0727
15 ARTHRITIS FUNGAL 5 0.0694
16 ENTEROBACTER PNEUMONIA 10 0.0641
17 HYPEROXALURIA 11 0.0640
18 CATABOLIC STATE 4 0.0597
19 PROCALCITONIN DECREASED 4 0.0571
20 CANDIDA ENDOPHTHALMITIS 6 0.0492
21 GEOTRICHUM INFECTION 10 0.0474
22 HYPERSENSITIVITY PNEUMONITIS 53 0.0465
23 ASYMPTOMATIC BACTERIURIA 6 0.0441
24 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 7 0.0435
25 EOSINOPHILIC PUSTULAR FOLLICULITIS 4 0.0430
26 VANCOMYCIN INFUSION REACTION 16 0.0424
27 SEPTIC PULMONARY EMBOLISM 8 0.0410
28 EOSINOPHILIC PLEURAL EFFUSION 12 0.0403
29 CORYNEBACTERIUM BACTERAEMIA 3 0.0353
30 SEPTIC ENCEPHALOPATHY 6 0.0349
31 SPLENIC EMBOLISM 4 0.0348
32 DRUG DISPENSED TO WRONG PATIENT 33 0.0346
33 HYPOPROTHROMBINAEMIA 10 0.0332
34 ACUTE INTERSTITIAL PNEUMONITIS 17 0.0326
35 CREATINE KINASE INCREASED 25 0.0325
36 DEVICE RELATED BACTERAEMIA 10 0.0323
37 CRYPTOCOCCAL CUTANEOUS INFECTION 5 0.0275
38 RETICULOCYTOPENIA 4 0.0274
39 PULMONARY EOSINOPHILIA 12 0.0262
40 STAPHYLOCOCCAL BACTERAEMIA 113 0.0260
41 BLADDER SPHINCTER ATONY 4 0.0258
42 FUSARIUM INFECTION 18 0.0257
43 DISSEMINATED ASPERGILLOSIS 12 0.0254
44 RECTAL PERFORATION 13 0.0241
45 DISSEMINATED MUCORMYCOSIS 9 0.0228
46 EOSINOPHILIA 387 0.0221
47 CRYSTALLURIA 12 0.0221
48 SYSTEMIC CANDIDA 55 0.0219
49 DIFFUSE ALVEOLAR DAMAGE 25 0.0217
50 CRYPTOCOCCAL FUNGAEMIA 3 0.0210
51 MEDIASTINITIS 12 0.0207
52 BLOOD CREATINE PHOSPHOKINASE 3 0.0205
53 PLASMABLASTIC LYMPHOMA 7 0.0196
54 URAEMIC ENCEPHALOPATHY 6 0.0192
55 GASTROINTESTINAL CANDIDIASIS 8 0.0191
56 URTICARIAL VASCULITIS 10 0.0189
57 SEPSIS SYNDROME 9 0.0179
58 HEPATIC CYTOLYSIS 227 0.0178
59 PNEUMONITIS CHEMICAL 6 0.0172
60 CHORIORETINITIS 11 0.0171
61 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 14 0.0170
62 CARDIAC VALVE VEGETATION 8 0.0165
63 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
64 TRANSFUSION-RELATED ACUTE LUNG INJURY 5 0.0162
65 MIXED ANXIETY AND DEPRESSIVE DISORDER 6 0.0162
66 RESPIRATORY GAS EXCHANGE DISORDER 6 0.0162
67 ENTEROCOCCAL INFECTION 78 0.0161
68 ENTEROCOCCAL SEPSIS 13 0.0160
69 ENTEROCOCCAL BACTERAEMIA 17 0.0160
70 PATHOGEN RESISTANCE 141 0.0155
71 NEPHRITIS ALLERGIC 6 0.0151
72 ALVEOLITIS ALLERGIC 15 0.0145
73 ENDOCARDITIS STAPHYLOCOCCAL 7 0.0142
74 INTERVERTEBRAL DISCITIS 26 0.0138
75 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 344 0.0134
76 AGRANULOCYTOSIS 246 0.0132
77 KOUNIS SYNDROME 29 0.0128
78 ENDOCARDITIS BACTERIAL 10 0.0127
79 GOUTY ARTHRITIS 10 0.0125
80 RED MAN SYNDROME 11 0.0125
81 HYPOPERFUSION 13 0.0124
82 MIXED LIVER INJURY 37 0.0123
83 UREAPLASMA INFECTION 5 0.0123
84 MYASTHENIA GRAVIS CRISIS 18 0.0121
85 HYPERCREATINAEMIA 4 0.0121
86 FUNGAL SEPSIS 10 0.0120
87 SEPTIC EMBOLUS 10 0.0120
88 CHOLURIA 4 0.0117
89 BLOOD CREATINE PHOSPHOKINASE INCREASED 329 0.0114
90 WRONG PATIENT RECEIVED PRODUCT 33 0.0113
91 CUTANEOUS VASCULITIS 41 0.0112
92 HAEMATOLOGICAL INFECTION 27 0.0110
93 PNEUMONIA NECROTISING 7 0.0108
94 ENTEROBACTER SEPSIS 4 0.0108
95 SKIN TEST POSITIVE 10 0.0107
96 THERAPEUTIC RESPONSE DELAYED 30 0.0107
97 DERMATOPHYTOSIS 3 0.0106
98 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 10 0.0106
99 HYPERGAMMAGLOBULINAEMIA 5 0.0103
100 CHOLESTATIC LIVER INJURY 23 0.0103
101 BACTERAEMIA 121 0.0102
102 FUNGAEMIA 16 0.0102
103 PARVOVIRUS INFECTION 4 0.0099
104 CHOLESTASIS 188 0.0098
105 ENDOCARDITIS 50 0.0097
106 ARTHRITIS BACTERIAL 40 0.0097
107 PNEUMONITIS 265 0.0097
108 LINEAR IGA DISEASE 16 0.0096
109 EPSTEIN-BARR VIRUS TEST POSITIVE 6 0.0095
110 BLOOD CULTURE POSITIVE 28 0.0093
111 CATHETER SITE RELATED REACTION 7 0.0093
112 RHABDOMYOLYSIS 389 0.0093
113 ENTEROCOCCUS TEST POSITIVE 6 0.0093
114 BRAIN ABSCESS 23 0.0091
115 CANDIDA SEPSIS 8 0.0089
116 SPINAL CORD DISORDER 14 0.0085
117 CYTOMEGALOVIRUS HEPATITIS 3 0.0085
118 GLOMERULAR FILTRATION RATE ABNORMAL 12 0.0085
119 KLEBSIELLA BACTERAEMIA 8 0.0084
120 NEUTROPENIC INFECTION 8 0.0084
121 LUNG OPACITY 22 0.0083
122 VISCERAL LEISHMANIASIS 6 0.0083
123 SOFT TISSUE INFECTION 15 0.0082
124 TOXIC EPIDERMAL NECROLYSIS 124 0.0082
125 ASPERGILLUS INFECTION 53 0.0081
126 PSOAS ABSCESS 5 0.0080
127 AXONAL NEUROPATHY 7 0.0080
128 PNEUMONIA PSEUDOMONAL 12 0.0078
129 STAPHYLOCOCCAL ABSCESS 5 0.0078
130 CHRONIC SPONTANEOUS URTICARIA 9 0.0078
131 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 60 0.0077
132 VASCULAR DEVICE INFECTION 35 0.0077
133 SYSTEMIC MYCOSIS 9 0.0077
134 MYOGLOBINURIA 4 0.0075
135 CORYNEBACTERIUM INFECTION 4 0.0075
136 RASH MACULO-PAPULAR 166 0.0075
137 STENOTROPHOMONAS INFECTION 10 0.0074
138 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 11 0.0072
139 PULMONARY TOXICITY 50 0.0071
140 CITROBACTER INFECTION 3 0.0070
141 VASCULITIS NECROTISING 5 0.0070
142 DEVICE RELATED SEPSIS 14 0.0069
143 MUCORMYCOSIS 18 0.0069
144 DIFFERENTIATION SYNDROME 5 0.0068
145 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 26 0.0068
146 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 3 0.0067
147 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
148 VASCULAR PURPURA 9 0.0064
149 MUSCLE ABSCESS 4 0.0064
150 CANDIDA INFECTION 107 0.0063
151 ESCHERICHIA SEPSIS 18 0.0062
152 C-REACTIVE PROTEIN DECREASED 4 0.0061
153 STAPHYLOCOCCAL SEPSIS 30 0.0061
154 NEUROLOGICAL DECOMPENSATION 14 0.0060
155 ARTERIOSPASM CORONARY 24 0.0060
156 AMAUROSIS 5 0.0059
157 MARROW HYPERPLASIA 4 0.0059
158 ORGANISING PNEUMONIA 29 0.0058
159 RASH MORBILLIFORM 16 0.0058
160 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
161 INTERSTITIAL LUNG DISEASE 275 0.0057
162 METABOLIC ALKALOSIS 9 0.0056
163 BACTERIAL DISEASE CARRIER 4 0.0055
164 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
165 DRUG RESISTANCE 139 0.0054
166 EOSINOPHIL COUNT INCREASED 45 0.0054
167 BRAIN STEM SYNDROME 4 0.0053
168 HUMAN HERPESVIRUS 6 INFECTION 10 0.0053
169 BLOOD FIBRINOGEN DECREASED 6 0.0053
170 MYOSITIS 47 0.0052
171 CAUDA EQUINA SYNDROME 4 0.0052
172 NEPHROGENIC DIABETES INSIPIDUS 6 0.0052
173 MULTIPLE-DRUG RESISTANCE 16 0.0052
174 HEPATITIS CHOLESTATIC 31 0.0051
175 HAEMODYNAMIC INSTABILITY 39 0.0051
176 EXTRADURAL ABSCESS 4 0.0051
177 IMPRISONMENT 9 0.0051
178 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
179 OLIGURIA 31 0.0050
180 STRONGYLOIDIASIS 8 0.0049
181 SPUTUM CULTURE POSITIVE 4 0.0049
182 MULTIPLE ORGAN DYSFUNCTION SYNDROME 139 0.0049
183 ORAL MUCOSA EROSION 6 0.0049
184 LUNG INFILTRATION 43 0.0049
185 ERYTHRODERMIC PSORIASIS 4 0.0049
186 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 6 0.0048
187 PULMONARY SEPSIS 7 0.0048
188 HEPATITIS ACUTE 31 0.0048
189 WRONG PRODUCT ADMINISTERED 32 0.0047
190 SEIZURE LIKE PHENOMENA 8 0.0047
191 AUTOIMMUNE HAEMOLYTIC ANAEMIA 16 0.0047
192 LIVER ABSCESS 15 0.0046
193 STAPHYLOCOCCAL INFECTION 150 0.0045
194 NECROTISING FASCIITIS 16 0.0045
195 ARTHRITIS INFECTIVE 21 0.0045
196 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
197 HYPERAMMONAEMIA 22 0.0044
198 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 33 0.0044
199 RENAL TUBULAR NECROSIS 43 0.0044
200 TOXIC SKIN ERUPTION 44 0.0044
201 LUNG CONSOLIDATION 12 0.0043
202 H1N1 INFLUENZA 6 0.0043
203 ACUTE RESPIRATORY FAILURE 82 0.0043
204 JAUNDICE CHOLESTATIC 15 0.0042
205 SUSPECTED OFF LABEL USE 19 0.0042
206 ACUTE MYELOID LEUKAEMIA RECURRENT 9 0.0042
207 HYPERSENSITIVITY VASCULITIS 11 0.0042
208 PERICARDIAL HAEMORRHAGE 9 0.0041
209 ENCEPHALOPATHY 101 0.0041
210 CROSS SENSITIVITY REACTION 4 0.0041
211 PULMONARY VALVE INCOMPETENCE 6 0.0041
212 ACUTE KIDNEY INJURY 628 0.0041
213 CELL DEATH 8 0.0040
214 PSEUDOMONAL SEPSIS 7 0.0040
215 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
216 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
217 CATHETER RELATED INFECTION 4 0.0039
218 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0039
219 MYOGLOBIN BLOOD INCREASED 6 0.0039
220 POTENTIATING DRUG INTERACTION 13 0.0039
221 ACUTE RESPIRATORY DISTRESS SYNDROME 68 0.0038
222 SINUS NODE DYSFUNCTION 7 0.0038
223 PNEUMONIA FUNGAL 15 0.0038
224 TUBULOINTERSTITIAL NEPHRITIS 71 0.0038
225 DYSENTERY 7 0.0038
226 KLEBSIELLA INFECTION 19 0.0038
227 DIABETES INSIPIDUS 9 0.0037
228 PSEUDOMONAS INFECTION 32 0.0037
229 HYPERLACTACIDAEMIA 10 0.0037
230 TOXOPLASMOSIS 4 0.0037
231 CATHETER SITE INFECTION 14 0.0037
232 HAEMORRHAGIC DISORDER 4 0.0037
233 ACINETOBACTER INFECTION 4 0.0037
234 OSTEOMYELITIS 66 0.0036
235 GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0036
236 INCISIONAL HERNIA 5 0.0036
237 SERUM SICKNESS 10 0.0036
238 SEPTIC SHOCK 156 0.0036
239 CULTURE URINE POSITIVE 5 0.0036
240 KLEBSIELLA SEPSIS 4 0.0035
241 HEPATOSPLENOMEGALY 9 0.0035
242 LICHENOID KERATOSIS 8 0.0035
243 FIXED ERUPTION 6 0.0035
244 CHOREA 6 0.0035
245 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 33 0.0035
246 MUCOSAL HAEMORRHAGE 4 0.0034
247 HYPERTRANSAMINASAEMIA 24 0.0034
248 HYPORESPONSIVE TO STIMULI 4 0.0034
249 PURPURA 30 0.0034
250 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0034
251 LIVEDO RETICULARIS 7 0.0033
252 PNEUMOMEDIASTINUM 6 0.0033
253 BONE MARROW DISORDER 10 0.0033
254 INFECTIOUS PLEURAL EFFUSION 5 0.0033
255 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
256 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
257 STREPTOCOCCAL INFECTION 18 0.0032
258 LEUKOPENIA 160 0.0032
259 HYPERAESTHESIA TEETH 4 0.0032
260 STEVENS-JOHNSON SYNDROME 70 0.0031
261 HAEMOLYTIC ANAEMIA 28 0.0031
262 HEPATOCELLULAR INJURY 44 0.0031
263 RESPIRATORY ALKALOSIS 5 0.0031
264 BICYTOPENIA 6 0.0031
265 PYODERMA GANGRENOSUM 11 0.0031
266 OXYGEN THERAPY 5 0.0030
267 LUNG DISORDER 148 0.0030
268 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 31 0.0030
269 HYPOVITAMINOSIS 4 0.0030
270 DRUG ERUPTION 53 0.0030
271 HIV INFECTION 9 0.0030
272 ENTEROBACTER INFECTION 5 0.0030
273 MYOCARDITIS 34 0.0030
274 DEVICE RELATED INFECTION 45 0.0029
275 DIVERTICULAR PERFORATION 6 0.0029
276 INTESTINAL ISCHAEMIA 16 0.0029
277 VASCULAR PSEUDOANEURYSM 5 0.0029
278 PANCYTOPENIA 160 0.0029
279 BACTERIAL INFECTION 53 0.0028
280 BRONCHOPULMONARY ASPERGILLOSIS 22 0.0028
281 GENERALISED OEDEMA 35 0.0028
282 FEBRILE BONE MARROW APLASIA 12 0.0028
283 ASTERIXIS 3 0.0028
284 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
285 NOSOCOMIAL INFECTION 6 0.0027
286 CLOSTRIDIUM TEST POSITIVE 6 0.0027
287 OTOTOXICITY 5 0.0027
288 PRODUCT LOT NUMBER ISSUE 6 0.0027
289 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 16 0.0027
290 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
291 MYCOBACTERIUM AVIUM COMPLEX INFECTION 7 0.0026
292 ADMINISTRATION SITE PAIN 3 0.0026
293 BLOOD CREATININE ABNORMAL 9 0.0026
294 TRAUMATIC LUNG INJURY 5 0.0026
295 THROMBOCYTOPENIA 288 0.0026
296 ATROPHY 5 0.0026
297 ESCHERICHIA INFECTION 21 0.0026
298 ESCHERICHIA BACTERAEMIA 6 0.0025
299 GASTROINTESTINAL STOMA COMPLICATION 4 0.0025
300 MULTI-ORGAN DISORDER 5 0.0025
301 BONE MARROW TOXICITY 3 0.0025
302 LONG QT SYNDROME 6 0.0025
303 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
304 CYTOMEGALOVIRUS INFECTION REACTIVATION 11 0.0025
305 IMMUNE-MEDIATED MYOCARDITIS 4 0.0025
306 GLOMERULONEPHRITIS 6 0.0024
307 RESPIRATORY DISTRESS 67 0.0024
308 PARAPLEGIA 7 0.0024
309 NEPHROPATHY TOXIC 27 0.0024
310 HEPATOTOXICITY 53 0.0024
311 OPTIC NEUROPATHY 5 0.0024
312 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
313 ABDOMINAL INFECTION 6 0.0023
314 CATHETER SITE PAIN 6 0.0023
315 APLASTIC ANAEMIA 12 0.0023
316 RESPIRATORY FAILURE 167 0.0023
317 FIBROSIS 7 0.0023
318 LEUKOCYTOSIS 41 0.0023
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
320 JUGULAR VEIN THROMBOSIS 4 0.0022
321 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
322 PSEUDOMEMBRANOUS COLITIS 5 0.0022
323 NEUTROPENIA 302 0.0022
324 IMMUNE THROMBOCYTOPENIA 10 0.0022
325 PNEUMONIA KLEBSIELLA 4 0.0022
326 TOXIC ENCEPHALOPATHY 11 0.0022
327 HEPATIC ENCEPHALOPATHY 20 0.0021
328 ABSCESS LIMB 9 0.0021
329 BONE MARROW TRANSPLANT 4 0.0021
330 FEBRILE NEUTROPENIA 139 0.0021
331 SUBCUTANEOUS ABSCESS 10 0.0021
332 HYPERKALAEMIA 73 0.0021
333 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 113 0.0021
334 NEUROTOXICITY 36 0.0021
335 HYPOXIA 72 0.0020
336 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
337 TRANSAMINASES INCREASED 45 0.0020
338 LACTIC ACIDOSIS 65 0.0020
339 HYPERCAPNIA 6 0.0020
340 CENTRAL VENOUS CATHETERISATION 6 0.0020
341 URINARY TRACT INFECTION BACTERIAL 5 0.0020
342 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
343 IMMUNE-MEDIATED HEPATITIS 4 0.0020
344 OSTEOLYSIS 4 0.0020
345 SKIN TOXICITY 11 0.0019
346 CYTOKINE RELEASE SYNDROME 39 0.0019
347 DERMATITIS BULLOUS 14 0.0019
348 DRUG LEVEL INCREASED 32 0.0019
349 BRAIN OEDEMA 24 0.0019
350 SEPSIS 211 0.0019
351 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
352 MALNUTRITION 21 0.0019
353 CATHETER SITE ERYTHEMA 4 0.0019
354 HYPERPHOSPHATAEMIA 4 0.0019
355 CRYPTOCOCCOSIS 3 0.0018
356 CLONUS 5 0.0018
357 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
358 ABDOMINAL ABSCESS 8 0.0018
359 BLOOD CREATINE INCREASED 8 0.0018
360 HAEMODIALYSIS 15 0.0018
361 DRUG-INDUCED LIVER INJURY 56 0.0018
362 CHILLS 209 0.0018
363 ACUTE PULMONARY OEDEMA 10 0.0018
364 RENAL TUBULAR DISORDER 5 0.0018
365 SUBARACHNOID HAEMORRHAGE 18 0.0018
366 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
367 C-REACTIVE PROTEIN INCREASED 64 0.0018
368 PUSTULAR PSORIASIS 6 0.0017
369 FUNGAL SKIN INFECTION 7 0.0017
370 HYPOKINESIA 25 0.0017
371 BILIRUBIN CONJUGATED INCREASED 4 0.0017
372 HYPERTHERMIA 13 0.0017
373 HEPATIC FAILURE 51 0.0017
374 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
375 PRODUCT ADMINISTRATION ERROR 34 0.0017
376 ANAL ABSCESS 9 0.0017
377 METABOLIC ENCEPHALOPATHY 5 0.0017
378 ATELECTASIS 16 0.0017
379 TREATMENT FAILURE 137 0.0017
380 SHOCK 38 0.0017
381 OESOPHAGITIS 18 0.0016
382 THROMBOTIC MICROANGIOPATHY 16 0.0016
383 LIVER INJURY 40 0.0016
384 INFLAMMATORY MARKER INCREASED 8 0.0016
385 LOWER RESPIRATORY TRACT INFECTION 73 0.0016
386 ORAL CANDIDIASIS 21 0.0016
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
388 PNEUMONIA VIRAL 5 0.0016
389 HAEMOLYSIS 12 0.0016
390 PERIORBITAL OEDEMA 8 0.0015
391 COAGULOPATHY 25 0.0015
392 POSTOPERATIVE WOUND INFECTION 10 0.0015
393 PLEURAL EFFUSION 90 0.0015
394 CLOSTRIDIAL INFECTION 5 0.0015
395 HAEMATOTOXICITY 14 0.0015
396 DECUBITUS ULCER 12 0.0015
397 CYTOPENIA 18 0.0015
398 PRODUCT DISPENSING ERROR 32 0.0015
399 HYPERURICAEMIA 6 0.0015
400 LEFT VENTRICULAR FAILURE 5 0.0015
401 CAPILLARY LEAK SYNDROME 3 0.0014
402 IMMUNE-MEDIATED MYOSITIS 4 0.0014
403 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
404 DRUG INTERACTION 230 0.0014
405 PETECHIAE 15 0.0014
406 ENDOTRACHEAL INTUBATION 4 0.0014
407 SKIN INFECTION 16 0.0014
408 THERAPY NON-RESPONDER 64 0.0014
409 HYPERPYREXIA 6 0.0014
410 LYMPHOPENIA 20 0.0014
411 NEUTROPHILIA 8 0.0014
412 PURULENT DISCHARGE 6 0.0014
413 PYREXIA 481 0.0014
414 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
415 ADENOVIRUS INFECTION 4 0.0014
416 HALLUCINATION, VISUAL 29 0.0014
417 TRANSPLANT REJECTION 11 0.0014
418 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
419 FAILURE TO THRIVE 7 0.0013
420 HEPATIC NECROSIS 5 0.0013
421 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
422 PLATELET COUNT ABNORMAL 8 0.0013
423 THERAPY CHANGE 13 0.0013
424 ACUTE HEPATIC FAILURE 18 0.0013
425 ECCHYMOSIS 9 0.0013
426 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
427 BLOOD CREATININE INCREASED 85 0.0013
428 ENCEPHALITIS 9 0.0013
429 PRODUCT USE IN UNAPPROVED INDICATION 321 0.0013
430 HEPATITIS 33 0.0013
431 ERYTHEMA MULTIFORME 12 0.0013
432 METABOLIC ACIDOSIS 41 0.0013
433 MENTAL STATUS CHANGES 35 0.0013
434 HYPERBILIRUBINAEMIA 13 0.0013
435 AZOTAEMIA 5 0.0013
436 GRAFT VERSUS HOST DISEASE 9 0.0013
437 ENTERITIS 8 0.0012
438 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
439 SHOCK HAEMORRHAGIC 10 0.0012
440 BACTERIAL SEPSIS 4 0.0012
441 MULTI-ORGAN FAILURE 21 0.0012
442 HYPERVOLAEMIA 6 0.0012
443 PERICARDIAL EFFUSION 28 0.0012
444 RENAL IMPAIRMENT 101 0.0012
445 PNEUMONIA BACTERIAL 11 0.0012
446 NEPHRITIS 4 0.0012
447 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
448 TACHYPNOEA 16 0.0012
449 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
450 PHLEBITIS 6 0.0012
451 AORTIC ARTERIOSCLEROSIS 3 0.0012
452 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
453 UNRESPONSIVE TO STIMULI 30 0.0012
454 SKIN NECROSIS 6 0.0012
455 COMPARTMENT SYNDROME 3 0.0011
456 LUNG TRANSPLANT 4 0.0011
457 PHARYNGEAL SWELLING 11 0.0011
458 SKIN WEEPING 4 0.0011
459 GASTRIC ULCER 21 0.0011
460 COVID-19 PNEUMONIA 13 0.0011
461 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
462 MYOCLONUS 13 0.0011
463 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
464 DIALYSIS 15 0.0011
465 CELLULITIS 53 0.0011
466 SKIN MASS 7 0.0010
467 ANAPHYLACTIC SHOCK 27 0.0010
468 RENAL FAILURE ACUTE 44 0.0010
469 VASCULITIS 12 0.0010
470 RHINOVIRUS INFECTION 4 0.0010
471 PULMONARY OEDEMA 46 0.0010
472 EXPIRED PRODUCT ADMINISTERED 34 0.0010
473 CYTOMEGALOVIRUS INFECTION 17 0.0010
474 PULMONARY HAEMORRHAGE 8 0.0010
475 VENOUS THROMBOSIS 4 0.0010
476 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
477 HAEMATOCRIT DECREASED 20 0.0010
478 CREPITATIONS 3 0.0010
479 BRAIN HERNIATION 3 0.0010
480 DERMATITIS EXFOLIATIVE 5 0.0010
481 SMALL INTESTINAL OBSTRUCTION 12 0.0010
482 HYPERCALCAEMIA 12 0.0010
483 NEPHROPATHY 9 0.0010
484 ACUTE MYELOID LEUKAEMIA 15 0.0010
485 ANGINA PECTORIS 27 0.0009
486 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
487 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
488 ANURIA 8 0.0009
489 HEPATOMEGALY 9 0.0009
490 URINE OUTPUT DECREASED 8 0.0009
491 RENAL FAILURE 121 0.0009
492 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10 0.0009
493 BK VIRUS INFECTION 3 0.0009
494 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
495 DRUG LEVEL DECREASED 9 0.0009
496 PERONEAL NERVE PALSY 5 0.0009
497 ABSCESS 14 0.0009
498 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
499 CARDIAC VALVE DISEASE 5 0.0009
500 NEUROLOGICAL SYMPTOM 5 0.0009
501 APLASIA PURE RED CELL 3 0.0009
502 ENTEROCOLITIS 5 0.0009
503 NEPHROGENIC ANAEMIA 4 0.0009
504 ELECTROLYTE IMBALANCE 10 0.0009
505 HAEMOPTYSIS 24 0.0009
506 RIGHT VENTRICULAR FAILURE 6 0.0009
507 UMBILICAL HERNIA 4 0.0009
508 TACHYCARDIA 76 0.0009
509 SKIN REACTION 12 0.0009
510 ARTERIOSCLEROSIS 8 0.0008
511 ACUTE MYOCARDIAL INFARCTION 25 0.0008
512 BRONCHOSPASM 12 0.0008
513 BONE LESION 3 0.0008
514 FACE OEDEMA 14 0.0008
515 FACIAL PARALYSIS 7 0.0008
516 DENTAL CARIES 9 0.0008
517 AMYLASE INCREASED 3 0.0008
518 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
519 NEUTROPHIL COUNT DECREASED 33 0.0008
520 PULMONARY MASS 12 0.0008
521 ABDOMINAL TENDERNESS 4 0.0008
522 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
523 OFF LABEL USE 703 0.0008
524 HYPERNATRAEMIA 4 0.0008
525 OXYGEN SATURATION DECREASED 45 0.0008
526 LIVER FUNCTION TEST ABNORMAL 23 0.0008
527 TROPONIN INCREASED 6 0.0008
528 PATHOLOGICAL FRACTURE 4 0.0008
529 NEURALGIA 19 0.0008
530 RENAL FAILURE CHRONIC 6 0.0008
531 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
532 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
533 RASH PRURITIC 42 0.0008
534 SINUS TACHYCARDIA 11 0.0008
535 PERITONITIS 16 0.0008
536 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
537 RASH ERYTHEMATOUS 36 0.0008
538 ANAEMIA 143 0.0007
539 CANDIDIASIS 3 0.0007
540 MYASTHENIA GRAVIS 6 0.0007
541 POST PROCEDURAL INFECTION 6 0.0007
542 PULMONARY FIBROSIS 14 0.0007
543 TREMOR 121 0.0007
544 CEREBRAL HAEMORRHAGE 26 0.0007
545 JOINT EFFUSION 5 0.0007
546 EMBOLISM 6 0.0007
547 DELIRIUM 25 0.0007
548 FUNGAL INFECTION 24 0.0007
549 BLOOD UREA INCREASED 12 0.0007
550 EXTRASYSTOLES 5 0.0007
551 END STAGE RENAL DISEASE 13 0.0007
552 SKIN PLAQUE 6 0.0007
553 MITRAL VALVE INCOMPETENCE 8 0.0007
554 ANAPHYLACTIC REACTION 39 0.0007
555 GENERALISED ERYTHEMA 4 0.0007
556 HYPOTENSION 141 0.0007
557 CARDIAC ARREST 58 0.0007
558 NEUTROPENIC SEPSIS 5 0.0007
559 SKIN HYPERPIGMENTATION 6 0.0007
560 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
561 CARDIOGENIC SHOCK 10 0.0007
562 PNEUMOTHORAX 11 0.0007
563 HYPOKALAEMIA 32 0.0007
564 BONE MARROW FAILURE 14 0.0007
565 PRODUCT PRESCRIBING ISSUE 15 0.0007
566 ATRIAL FIBRILLATION 67 0.0007
567 TOOTH ABSCESS 7 0.0007
568 RASH PUSTULAR 5 0.0007
569 CONFUSIONAL STATE 110 0.0007
570 INFECTION 98 0.0007
571 HYPOPHOSPHATAEMIA 5 0.0007
572 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
573 CONDITION AGGRAVATED 204 0.0007
574 FOLLICULITIS 7 0.0007
575 PANCREATITIS ACUTE 15 0.0007
576 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
577 SUDDEN DEATH 7 0.0007
578 RASH GENERALISED 17 0.0007
579 SKIN LESION 18 0.0007
580 HAEMATOMA 17 0.0007
581 RESTLESSNESS 24 0.0007
582 RESPIRATORY TRACT INFECTION 17 0.0007
583 LIPASE INCREASED 5 0.0007
584 PNEUMONIA 211 0.0007
585 RASH 282 0.0006
586 DERMATITIS ALLERGIC 8 0.0006
587 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
588 TRICUSPID VALVE INCOMPETENCE 5 0.0006
589 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
590 APHAGIA 3 0.0006
591 SINUS BRADYCARDIA 6 0.0006
592 PLATELET COUNT DECREASED 66 0.0006
593 SKIN ULCER 16 0.0006
594 FLUID OVERLOAD 9 0.0006
595 HIATUS HERNIA 8 0.0006
596 ASCITES 18 0.0006
597 BREATH SOUNDS ABNORMAL 3 0.0006
598 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
599 ADVERSE REACTION 8 0.0006
600 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
601 LIP SWELLING 20 0.0006
602 HYPOTHERMIA 6 0.0006
603 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
604 AMMONIA INCREASED 3 0.0006
605 ANGIOEDEMA 26 0.0006
606 CHOLECYSTITIS 7 0.0006
607 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
608 BLOOD PRESSURE FLUCTUATION 14 0.0006
609 DRUG INEFFECTIVE 768 0.0006
610 RASH PAPULAR 13 0.0006
611 LOCALISED INFECTION 14 0.0006
612 NERVOUS SYSTEM DISORDER 18 0.0006
613 HYPOMAGNESAEMIA 8 0.0006
614 OEDEMA 31 0.0006
615 MYALGIA 97 0.0006
616 BLOOD LACTIC ACID INCREASED 3 0.0006
617 PAPULE 4 0.0006
618 HAEMOGLOBIN DECREASED 58 0.0006
619 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
620 MYELOSUPPRESSION 20 0.0006
621 BLOOD BILIRUBIN INCREASED 15 0.0006
622 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
623 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
624 BLISTER 31 0.0006
625 HYPONATRAEMIA 31 0.0005
626 HYPOPHAGIA 14 0.0005
627 CARDIOMYOPATHY 8 0.0005
628 HYPERTENSIVE CRISIS 6 0.0005
629 LYMPHADENOPATHY 19 0.0005
630 HAEMORRHAGE INTRACRANIAL 8 0.0005
631 MUCOSAL INFLAMMATION 14 0.0005
632 FISTULA 6 0.0005
633 FLANK PAIN 5 0.0005
634 HEART RATE IRREGULAR 12 0.0005
635 PULMONARY CONGESTION 7 0.0005
636 REBOUND EFFECT 6 0.0005
637 HEPATIC ENZYME INCREASED 36 0.0005
638 CARDIO-RESPIRATORY ARREST 22 0.0005
639 DERMATITIS 11 0.0005
640 DISEASE PROGRESSION 62 0.0005
641 ACIDOSIS 4 0.0005
642 SEROTONIN SYNDROME 10 0.0005
643 PNEUMONIA ASPIRATION 13 0.0005
644 LIVER FUNCTION TEST INCREASED 11 0.0005
645 SWOLLEN TONGUE 16 0.0005
646 SKIN EXFOLIATION 43 0.0005
647 RENAL INJURY 15 0.0005
648 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
649 FEELING COLD 14 0.0005
650 MUSCLE RIGIDITY 6 0.0005
651 URTICARIA 84 0.0005
652 PERITONITIS BACTERIAL 5 0.0005
653 MUSCLE DISORDER 4 0.0005
654 BLOOD POTASSIUM INCREASED 8 0.0005
655 NO THERAPEUTIC RESPONSE 6 0.0005
656 ORAL PAIN 11 0.0005
657 POLYURIA 4 0.0005
658 RASH MACULAR 17 0.0005
659 PHOTOSENSITIVITY REACTION 8 0.0005
660 SPINAL COMPRESSION FRACTURE 4 0.0005
661 HEPATIC STEATOSIS 9 0.0005
662 HEPATIC FUNCTION ABNORMAL 18 0.0005
663 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
664 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
665 INFUSION SITE ERYTHEMA 4 0.0005
666 CIRCULATORY COLLAPSE 8 0.0005
667 HAEMATURIA 16 0.0005
668 PRESCRIBED OVERDOSE 9 0.0005
669 MYOPATHY 4 0.0005
670 PULMONARY EMBOLISM 44 0.0005
671 SPINAL OSTEOARTHRITIS 4 0.0005
672 TUMOUR LYSIS SYNDROME 4 0.0005
673 PANCREATITIS 24 0.0005
674 IMMUNOSUPPRESSION 4 0.0005
675 APPETITE DISORDER 3 0.0005
676 RESPIRATORY RATE INCREASED 4 0.0005
677 VENTRICULAR FIBRILLATION 5 0.0004
678 CARDIAC FAILURE 36 0.0004
679 INTESTINAL PERFORATION 5 0.0004
680 INFUSION RELATED REACTION 29 0.0004
681 LETHARGY 25 0.0004
682 CHRONIC KIDNEY DISEASE 33 0.0004
683 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
684 ERYTHEMA 88 0.0004
685 SPLENOMEGALY 5 0.0004
686 DYSARTHRIA 16 0.0004
687 LEUKAEMIA 4 0.0004
688 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
689 ATAXIA 5 0.0004
690 ECZEMA 22 0.0004
691 OEDEMA PERIPHERAL 51 0.0004
692 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
693 POLYNEUROPATHY 5 0.0004
694 PERICARDITIS 7 0.0004
695 BURSITIS 5 0.0004
696 DYSPNOEA 233 0.0004
697 AUTOIMMUNE DISORDER 4 0.0004
698 VITAMIN D DEFICIENCY 4 0.0004
699 CEREBRAL INFARCTION 10 0.0004
700 PSYCHOTIC DISORDER 12 0.0004
701 CEREBRAL DISORDER 3 0.0004
702 PALLOR 11 0.0004
703 PRODUCT STORAGE ERROR 35 0.0004
704 EMPHYSEMA 4 0.0004
705 RECTAL HAEMORRHAGE 17 0.0004
706 PHARYNGEAL OEDEMA 6 0.0004
707 LYMPHOMA 6 0.0004
708 LIMB DISCOMFORT 12 0.0004
709 EJECTION FRACTION DECREASED 6 0.0004
710 VENTRICULAR EXTRASYSTOLES 4 0.0004
711 HYPERSENSITIVITY 71 0.0004
712 TRANSFUSION 4 0.0004
713 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
714 NEUROPATHY PERIPHERAL 36 0.0004
715 BLOOD ALBUMIN DECREASED 3 0.0004
716 ATRIAL FLUTTER 3 0.0004
717 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
718 HEPATIC CIRRHOSIS 7 0.0004
719 HYPOCALCAEMIA 7 0.0004
720 THROAT TIGHTNESS 10 0.0004
721 COLITIS 14 0.0004
722 WOUND INFECTION 4 0.0004
723 ASPIRATION 4 0.0004
724 EPILEPSY 11 0.0004
725 BONE PAIN 21 0.0004
726 DEVICE OCCLUSION 5 0.0004
727 STATUS EPILEPTICUS 4 0.0004
728 DISORIENTATION 14 0.0004
729 DERMATITIS CONTACT 4 0.0004
730 THERAPY CESSATION 18 0.0004
731 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
732 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
733 SUBDURAL HAEMATOMA 5 0.0003
734 CARDIAC OPERATION 3 0.0003
735 BLOOD MAGNESIUM DECREASED 3 0.0003
736 EPISTAXIS 26 0.0003
737 PRURITUS 133 0.0003
738 CHEST PAIN 64 0.0003
739 INTENTIONAL PRODUCT MISUSE 30 0.0003
740 LIVER DISORDER 15 0.0003
741 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
742 PULMONARY HYPERTENSION 7 0.0003
743 PRODUCT PRESCRIBING ERROR 8 0.0003
744 HYPERLIPIDAEMIA 4 0.0003
745 RESPIRATORY DISORDER 10 0.0003
746 HALLUCINATION 25 0.0003
747 LIMB INJURY 9 0.0003
748 TENDON RUPTURE 4 0.0003
749 OSTEONECROSIS OF JAW 8 0.0003
750 TENDONITIS 5 0.0003
751 LUNG INFECTION 5 0.0003
752 DEFORMITY 3 0.0003
753 THERAPY PARTIAL RESPONDER 5 0.0003
754 TOXICITY TO VARIOUS AGENTS 54 0.0003
755 MELAENA 7 0.0003
756 CYANOSIS 5 0.0003
757 MUSCULOSKELETAL DISORDER 6 0.0003
758 SEIZURE 36 0.0003
759 PRODUCT USE ISSUE 58 0.0003
760 PRODUCT AVAILABILITY ISSUE 7 0.0003
761 ASTHENIA 115 0.0003
762 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
763 HYPERGLYCAEMIA 11 0.0003
764 BRAIN INJURY 3 0.0003
765 JAUNDICE 8 0.0003
766 BODY TEMPERATURE INCREASED 6 0.0003
767 COMA 14 0.0003
768 DRUG TOXICITY 4 0.0003
769 RESPIRATORY ARREST 8 0.0003
770 HYPOGLYCAEMIA 14 0.0003
771 CARDIAC FAILURE CONGESTIVE 23 0.0003
772 LYMPHOCYTE COUNT DECREASED 5 0.0003
773 PAIN IN JAW 8 0.0003
774 DEEP VEIN THROMBOSIS 18 0.0003
775 WHEEZING 16 0.0003
776 URINARY TRACT INFECTION 46 0.0003
777 SNEEZING 6 0.0003
778 MALAISE 117 0.0003
779 ANHEDONIA 7 0.0003
780 FEELING HOT 16 0.0003
781 MUSCULOSKELETAL CHEST PAIN 4 0.0003
782 DELUSION 4 0.0003
783 BURNING SENSATION 18 0.0003
784 PREMATURE DELIVERY 4 0.0003
785 WOUND 7 0.0003
786 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
787 COUGH 70 0.0002
788 ABDOMINAL PAIN 58 0.0002
789 ADRENAL INSUFFICIENCY 3 0.0002
790 GASTROINTESTINAL DISORDER 22 0.0002
791 CARDIOMEGALY 3 0.0002
792 NAUSEA 193 0.0002
793 METASTASES TO BONE 4 0.0002
794 IMPAIRED HEALING 8 0.0002
795 TOOTH LOSS 5 0.0002
796 BLOOD PRESSURE DECREASED 16 0.0002
797 DYSSTASIA 7 0.0002
798 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
799 KNEE ARTHROPLASTY 5 0.0002
800 SCAR 4 0.0002
801 DEHYDRATION 31 0.0002
802 ARRHYTHMIA 11 0.0002
803 DYSPHAGIA 22 0.0002
804 NEOPLASM PROGRESSION 8 0.0002
805 AMENORRHOEA 4 0.0002
806 METASTASES TO LIVER 4 0.0002
807 BRADYCARDIA 12 0.0002
808 FREQUENT BOWEL MOVEMENTS 6 0.0002
809 TOOTHACHE 4 0.0002
810 MUSCULAR WEAKNESS 25 0.0002
811 BACK PAIN 51 0.0002
812 BONE DISORDER 4 0.0002
813 NIGHT SWEATS 7 0.0002
814 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
815 CHOLELITHIASIS 7 0.0002
816 OVERDOSE 46 0.0002
817 INFLAMMATION 11 0.0002
818 OSTEONECROSIS 7 0.0002
819 SLEEP DISORDER 15 0.0002
820 DYSPNOEA EXERTIONAL 8 0.0002
821 UNEVALUABLE EVENT 16 0.0002
822 COVID-19 37 0.0002
823 HAEMORRHAGE 22 0.0002
824 PROTEINURIA 4 0.0002
825 DISEASE RECURRENCE 10 0.0002
826 SPEECH DISORDER 11 0.0002
827 HYPERHIDROSIS 27 0.0002
828 PRODUCTIVE COUGH 10 0.0002
829 VOMITING 98 0.0002
830 EAR PAIN 4 0.0002
831 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
832 APHASIA 6 0.0002
833 DIARRHOEA 128 0.0002
834 SKIN DISCOLOURATION 9 0.0002
835 DRUG ADMINISTRATION ERROR 6 0.0002
836 CHEST DISCOMFORT 20 0.0002
837 PRODUCT PREPARATION ERROR 4 0.0002
838 DEATH 167 0.0002
839 NO ADVERSE EVENT 35 0.0002
840 DEAFNESS 5 0.0002
841 GASTRITIS 5 0.0002
842 DECREASED APPETITE 44 0.0002
843 FEAR 5 0.0002
844 SKIN CANCER 4 0.0002
845 DISTURBANCE IN ATTENTION 10 0.0002
846 PRURITUS GENERALISED 4 0.0002
847 SWELLING FACE 12 0.0002
848 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
849 TREATMENT NONCOMPLIANCE 10 0.0002
850 STOMATITIS 11 0.0002
851 SYNCOPE 18 0.0002
852 SKIN DISORDER 6 0.0002
853 HYPERTENSION 38 0.0002
854 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
855 ARTHRALGIA 73 0.0002
856 JOINT SWELLING 21 0.0002
857 RENAL DISORDER 8 0.0002
858 PARAESTHESIA 27 0.0002
859 HEART RATE INCREASED 17 0.0002
860 URINARY INCONTINENCE 5 0.0002
861 DIABETIC KETOACIDOSIS 4 0.0002
862 ACCIDENTAL OVERDOSE 6 0.0002
863 EYE SWELLING 6 0.0002
864 NECK PAIN 9 0.0002
865 AGEUSIA 4 0.0002
866 SWELLING 15 0.0002
867 BLOOD URINE PRESENT 3 0.0002
868 HAEMATEMESIS 4 0.0002
869 CYSTITIS 5 0.0002
870 HERPES ZOSTER 9 0.0002
871 HYPOTHYROIDISM 5 0.0002
872 CHOKING 3 0.0002
873 AGITATION 11 0.0001
874 GAIT INABILITY 5 0.0001
875 FATIGUE 116 0.0001
876 DYSKINESIA 6 0.0001
877 VISUAL IMPAIRMENT 18 0.0001
878 EXPOSURE DURING PREGNANCY 9 0.0001
879 BLOOD PRESSURE INCREASED 22 0.0001
880 ABDOMINAL DISTENSION 15 0.0001
881 HEART RATE DECREASED 5 0.0001
882 LOSS OF CONSCIOUSNESS 18 0.0001
883 OROPHARYNGEAL PAIN 13 0.0001
884 HYPERSOMNIA 4 0.0001
885 PAIN 84 0.0001
886 GAIT DISTURBANCE 26 0.0001
887 LABORATORY TEST ABNORMAL 4 0.0001
888 ADVERSE DRUG REACTION 12 0.0001
889 CHROMATURIA 3 0.0001
890 INTESTINAL OBSTRUCTION 5 0.0001
891 CORONARY ARTERY DISEASE 4 0.0001
892 MYOCARDIAL INFARCTION 23 0.0001
893 DIABETES MELLITUS 10 0.0001
894 TINNITUS 6 0.0001
895 FALL 43 0.0001
896 INJURY 9 0.0001
897 INCORRECT DOSE ADMINISTERED 29 0.0001
898 PERIPHERAL SWELLING 19 0.0001
899 WEIGHT DECREASED 34 0.0001
900 ABASIA 3 0.0001
901 DYSPHONIA 7 0.0001
902 TYPE 2 DIABETES MELLITUS 4 0.0001
903 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
904 CARDIOVASCULAR DISORDER 3 0.0001
905 OSTEOARTHRITIS 5 0.0001
906 HOSPITALISATION 18 0.0001
907 DIZZINESS 58 0.0001
908 SUICIDE ATTEMPT 7 0.0001
909 MUSCULOSKELETAL PAIN 6 0.0001
910 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
911 THERAPY INTERRUPTED 8 0.0001
912 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
913 THROMBOSIS 9 0.0001
914 SKIN IRRITATION 5 0.0001
915 BRONCHITIS 8 0.0001
916 MEDICATION ERROR 6 0.0001
917 DEMENTIA 3 0.0001
918 COGNITIVE DISORDER 5 0.0001
919 CONVULSION 6 0.0001
920 SOMNOLENCE 21 0.0001
921 PLASMA CELL MYELOMA 4 0.0001
922 SURGERY 6 0.0001
923 ABDOMINAL DISCOMFORT 17 0.0001
924 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
925 CONSTIPATION 22 0.0001
926 CEREBROVASCULAR ACCIDENT 17 0.0001
927 BLOOD POTASSIUM DECREASED 3 0.0001
928 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
929 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
930 HEADACHE 62 0.0001
931 EXTRA DOSE ADMINISTERED 4 0.0001
932 DISCOMFORT 6 0.0001
933 SUICIDAL IDEATION 9 0.0001
934 FLUID RETENTION 5 0.0001
935 MUSCLE SPASMS 18 0.0001
936 ADVERSE EVENT 9 0.0001
937 DRUG INTOLERANCE 9 0.0001
938 MENTAL DISORDER 4 0.0001
939 EMOTIONAL DISTRESS 11 0.0001
940 ARTHROPATHY 5 0.0001
941 PAIN IN EXTREMITY 26 0.0001
942 NEPHROLITHIASIS 4 0.0001
943 INSOMNIA 23 0.0001
944 ANXIETY 24 0.0001
945 OCULAR HYPERAEMIA 4 0.0001
946 CONTUSION 8 0.0001
947 ABDOMINAL PAIN UPPER 17 0.0001
948 DYSPEPSIA 8 0.0001
949 SINUSITIS 8 0.0001
950 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
951 CARDIAC DISORDER 7 0.0001
952 BLOOD GLUCOSE INCREASED 14 0.0001
953 DRUG EFFECT DECREASED 4 0.0001
954 DEVICE BREAKAGE 3 0.0001
955 HYPOAESTHESIA 11 0.0001
956 VISION BLURRED 10 0.0001
957 MEMORY IMPAIRMENT 10 0.0001
958 HAEMATOCHEZIA 4 0.0001
959 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
960 MOBILITY DECREASED 5 0.0001
961 BALANCE DISORDER 6 0.0001
962 FLUSHING 7 0.0001
963 PALPITATIONS 8 0.0001
964 ILLNESS 7 0.0001
965 COLITIS ULCERATIVE 3 0.0001
966 WEIGHT INCREASED 15 0.0001
967 PRODUCT QUALITY ISSUE 9 0.0001
968 DEPRESSION 15 0.0001
969 ILL-DEFINED DISORDER 4 0.0001
970 VERTIGO 4 0.0001
971 NASOPHARYNGITIS 12 0.0001
972 BLOOD CHOLESTEROL INCREASED 3 0.0001
973 INFLUENZA 7 0.0001
974 ASTHMA 7 0.0001
975 ALOPECIA 11 0.0001
976 DYSGEUSIA 4 0.0001
977 HOT FLUSH 4 0.0001
978 ARTHRITIS 4 0.0001
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
980 DRY MOUTH 4 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
982 INJECTION SITE ERYTHEMA 6 0.0000
983 DRY SKIN 6 0.0000
984 PRODUCT DOSE OMISSION ISSUE 13 0.0000
985 DEVICE MALFUNCTION 3 0.0000
986 MIGRAINE 4 0.0000
987 FEELING ABNORMAL 10 0.0000
988 ACNE 3 0.0000
989 PSORIASIS 5 0.0000
990 DEVICE ISSUE 3 0.0000
991 BREAST CANCER 3 0.0000
992 DRUG DOSE OMISSION 5 0.0000
993 INJECTION SITE PAIN 7 0.0000